|
|
2945 Wilderness Place, Suite 100
Boulder, CO 80301 USA
phone:303 420 4420
fax:303 420 4426
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.bolderbio.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Human protein pharmaceuticals from protein engineering technologies. |
|
| Management |
| George Cox, Ph.D., President and Chief Scientific Officer |
| |
|
|
| |
|
| Keywords |
| protein, pharmaceuticals, engineering, cancer, endocrine, infectious diseases, hematology, InfectiousDisease |
|
|
|
| Description |
|
Bolder BioTechnology uses protein engineering technologies to create proprietary human protein pharmaceuticals with enhanced therapeutic properties. |
|
| Products / Services |
Bolder BioTechnology has a diversified pipeline human protein pharmaceuticals that include potential treatments for hematological and endocrine disorders, cancer and infectious disease.
|
|
| Technology / Differentiation |
| Bolder Biotechnology uses two protein engineering technologies, Site-Specific PEGylation and ImmunoFusion Protein technology, to create proprietary products. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members